Carisma Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CARM and buy or sell other stocks, ETFs, and their options commission-free!About CARM
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors.
CEOSteven Kelly
CEOSteven Kelly
Employees46
Employees46
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2016
Founded2016
Employees46
Employees46
CARM Key Statistics
Market cap1.99M
Market cap1.99M
Price-Earnings ratio0.30
Price-Earnings ratio0.30
Dividend yield—
Dividend yield—
Average volume656.27K
Average volume656.27K
High today$0.06
High today$0.06
Low today$0.0476
Low today$0.0476
Open price$0.052
Open price$0.052
Volume123.74K
Volume123.74K
52 Week high$1.27
52 Week high$1.27
52 Week low$0.0261
52 Week low$0.0261
Stock Snapshot
As of today, Carisma Therapeutics(CARM) shares are valued at $0.05. The company's market cap stands at 1.99M, with a P/E ratio of 0.30.
During the trading session on 2025-12-15, Carisma Therapeutics(CARM) shares reached a daily high of $0.06 and a low of $0.05. At a current price of $0.05, the stock is 0.0% higher than the low and still -20.7% under the high.
Trading activity shows a volume of 123.74K, compared to an average daily volume of 656.27K.
The stock's 52-week range extends from a low of $0.03 to a high of $1.27.
The stock's 52-week range extends from a low of $0.03 to a high of $1.27.
People also own
Based on the portfolios of people who own CARM. This list is generated using Robinhood data, and it’s not a recommendation.